Kamitsuji, Y <br/><br/>
The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias.  [electronic resource] 

 -  Cell death and differentiation  Nov 2008 
 - 1712-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1350-9047 
<br/><br/><label>Standard No.: </label>10.1038/cdd.2008.107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosomes--drug effects<br/>Autophagy--drug effects<br/>Caspases--metabolism<br/>Cell Line, Tumor<br/>Chloroquine--pharmacology<br/>Cytoprotection--drug effects<br/>Disease Models, Animal<br/>Enzyme Activation--drug effects<br/>Fusion Proteins, bcr-abl--antagonists & inhibitors<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--enzymology<br/>Male<br/>Mice<br/>Mice, SCID<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrimidines--pharmacology<br/>Xenograft Model Antitumor Assays